ClinicalTrials.Veeva

Find clinical trials for Alzheimer's Disease in Baltimore, MD

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Alzheimer Disease
Dementia
Cognitive Dysfunction
Brain Diseases
Mental Disorders
Neurodegenerative Diseases
Nervous System Diseases

Alzheimer's Disease trials near Baltimore, MD, USA:

A Study to Evaluate the Safety and Efficacy of CT1812 in Early Alzheimer's Disease

designed to evaluate the efficacy, safety, and tolerability of two doses of CT1812 compared to placebo in participants diagnosed with early Alzheimer's...

Enrolling
Early Alzheimer's Disease
Drug: Placebo
Drug: CT1812

Phase 2

Cognition Therapeutics
Cognition Therapeutics

Washington, District of Columbia, United States of America and 12 other locations

This is a randomized, double-blind, sham-controlled, adaptive-design pivotal study of sensory stimulation in subjects with mild to moderate Alzheimer's...

Enrolling
Alzheimer Disease 6
Dementia of Alzheimer Type
Device: Sensory Stimulation System (GS120) - Sham
Device: Sensory Stimulation System (GS120) - Active
Cognito Therapeutics
Cognito Therapeutics

Fairfax, Virginia, United States and 67 other locations

The purpose of this study is to determine whether daily treatment with this new treatment approach, called COT would be effective in protecting the m...

Enrolling
Early Alzheimer's Disease
Mild Cognitive Impairment
Drug: COT
Drug: Sham

Phase 2

EvOn Medics

Washington, District of Columbia, United States and 2 other locations

The reason for this study is to collect safety and efficacy information regarding the study drug remternetug in participants with early Alzheimer's...

Enrolling
Alzheimer's Disease
Drug: Remternetug (SC)
Drug: Placebo

Phase 3

Lilly
Lilly

Fairfax, Virginia, United States and 76 other locations

This study is designed to evaluate safety and efficacy of fosgonimeton (ATH-1017) in the treatment of mild to moderate Alzheimer's disease...

Active, not recruiting
Alzheimer Disease
Dementia of Alzheimer Type
Drug: Placebo
Drug: ATH-1017

Phase 2, Phase 3

Athira Pharma
Athira Pharma

Baltimore, Maryland, United States and 89 other locations

progression of AD, as compared to no stimulation (OFF), by measuring baseline (pre-implantation) to 12-month change in the integrated Alzheimer's...

Active, not recruiting
Alzheimer Disease
Device: DBS-f On
Device: DBS Off
Functional Neuromodulation

Baltimore, Maryland, United States and 20 other locations

To investigate safety, tolerability, the effects on cognition and brain metabolism of pepinemab in early AD dementia (early AD) subjects.

Active, not recruiting
Alzheimer Disease
Drug: Placebo
Drug: Pepinemab

Phase 1, Phase 2

Vaccinex

Washington, District of Columbia, United States and 13 other locations

is superior to placebo on change from baseline of the Preclinical Alzheimer Cognitive Composite 5 (PACC5) at 216 weeks of treatment (A45 Tri...

Enrolling
Preclinical Alzheimer's Disease
Early Preclinical Alzheimer's Disease
Drug: Lecanemab
Drug: Placebo

Phase 3

Eisai
Eisai

Baltimore, Maryland, United States and 111 other locations

Alzheimer's disease (AD) is a progressive, irreversible neurological disorder and is the most common cause of dementia in the elder...

Enrolling
Alzheimer's Disease (AD)
Drug: Placebo
Drug: ABBV-916

Phase 2

AbbVie
AbbVie

Fairfax, Virginia, United States and 36 other locations

This is an open-label long term extension study for participants with Alzheimer's disease (AD) who have completed Protocol TB006AD2...

Active, not recruiting
Alzheimer's Disease
Drug: TB006

Phase 2

TrueBinding

Fairfax, Virginia, United States and 12 other locations

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems